Lv2
146 积分 2022-02-11 加入
Intrapleural anti-PD-1 antibody for the treatment of advanced non-small cell lung cancer with malignant pleural effusion: a prospective, single-arm, single-center, phase I trial
11天前
已完结
The effect of preoperative radiotherapy on local control and prognosis in high-grade non-metastatic intramedullary osteosarcoma of the extremities
22天前
已完结
Effects of endostar combined multidrug chemotherapy in osteosarcoma
23天前
已完结
FLAIR: A Phase II, Open Label, Randomized Study of Osimertinib Plus Bevacizumab Versus Osimertinib in Recurrent or Metastatic Treatment-Naïve NSCLC Patients Harboring EGFR 21L858R Mutation
1个月前
已完结
AZD9291 (Osimertinib) With or Without Bevacizumab as First-Treatment for Patients With EGFR-Mutant Lung Cancer
1个月前
已关闭
Reduced/No Dexamethasone With Netupitant/Palonosetron and Olanzapine for Chemotherapy‑Induced Nausea/Vomiting in Highly Emetogenic Chemotherapy: Phase III Noninferiority Trial
2个月前
已完结
Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trial
5个月前
已完结
Longitudinal circulating tumor DNA monitoring in predicting response to short-course radiotherapy followed by neoadjuvant chemotherapy and camrelizumab in locally advanced rectal cancer: data from a Phase Ⅲ clinical trial (UNION)
5个月前
已完结
[Expert consensus on ensartinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer]
6个月前
已完结
Efficacy and safety of ensartinib in the treatment of non-small cell lung cancer: A systematic review of clinical trials
6个月前
已完结
皖公网安备34019202002308
